RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
Abstract:
The invention relates to isolated nucleic acids and rAAV-based compositions, methods and kits useful for treating genetic diseases (e.g., alpha-1 antitrypsin deficiency).
Information query
Patent Agency Ranking
0/0